Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Dosing under way in phase IIa nociceptive pain study of cannabinor

July 4, 2006

SBIR grant supports ArmaGen's development of AGT-140 for stroke

July 4, 2006

Antipsychotic, antidepressant agents disclosed in recent patents

July 3, 2006

Approvable letter for Fentora in breakthrough cancer pain

July 3, 2006

Daytrana now available

June 30, 2006

Mirtazapine results in obstructive sleep apnea do not warrant further studies

June 30, 2006

Gantacurium chloride completes phase II study in endotracheal intubation

June 30, 2006

ELI-154 completes second pilot phase I study

June 30, 2006

Sosei and Mundipharma sign agreement for AD-923

June 30, 2006

European approval for Tysabri in MS

June 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...